Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 04/24 10:24:23 am
17450 ILa   -2.51%
1d agoDJActavis Settles Celebrex Case With Pfizer -- Update
1d ago TEVA PHARMACEUTICAL : Pride-HD Study Enrolling Patients Globally to Further..
4d ago TEVA PHARMACEUTICAL : Pfizer settle patent lawsuit
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

07/01/2013 | 07:27am US/Eastern
Recommend:
0
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
Recommend :
0
React to this article
Latest news on TEVA PHARMACEUTICAL INDUST
1d agoDJActavis Settles Celebrex Case With Pfizer -- Update
1d ago TEVA PHARMACEUTICAL : Pride-HD Study Enrolling Patients Globally to Further Eval..
4d ago TEVA PHARMACEUTICAL : Pfizer settle patent lawsuit
6d ago TEVA PHARMACEUTICAL : Announces Supreme Court Denial of Request for Interim Reli..
04/18 TEVA PHARMACEUTICAL : Introduces Generic Lunesta Tablets in the United States
04/17 TEVA PHARMACEUTICAL : Settles Patent Litigation with Pfizer on Celebrex®
04/16 TEVA PHARMACEUTICAL : Patent Issued for Dispersions of Rasagiline Citrate
04/16 TEVA PHARMACEUTICAL : Announces First Approval and Launch of Generic Lovaza® Cap..
04/15 TEVA PHARMACEUTICAL : Announces Launch of Generic Lunesta® Tablets in the United..
04/09 TEVA PHARMACEUTICAL : Announces U.S. Supreme Court Will Hear Its Appeal on COPAX..
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
Teva Pharmaceutical Indust : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF